Related Experiment Videos
Problems in Maintenance ECT in Bipolar Disorder: Replacement by Lithium and Anticonvulsants
Richard L. Jaffe1, Wendy Rives, William R. Dubin
1Philadelphia Psychiatric Center, Philadelphia, Pennsylvania, USA.
Summary
Electroconvulsive therapy (ECT) was ineffective for three elderly patients with atypical bipolar disorder, who improved with mood stabilizers like lithium and valproic acid. This highlights challenges in treating complex bipolar disorder cases.
Area of Science:
- Psychiatry
- Neurology
- Pharmacology
Background:
- Electroconvulsive therapy (ECT) is a common treatment for severe mood disorders.
- Some patients with bipolar disorder exhibit atypical presentations and treatment resistance.
- Maintenance pharmacotherapy is a cornerstone of long-term bipolar disorder management.
Purpose of the Study:
- To report on three elderly patients with atypical bipolar disorder experiencing poor outcomes with ECT.
- To explore alternative treatment strategies for treatment-resistant bipolar disorder.
- To discuss the diagnostic and therapeutic challenges in atypical bipolar disorder.
Main Methods:
- Case series describing three elderly patients with bipolar disorder.
- Review of treatment history, including electroconvulsive therapy (ECT) and pharmacotherapy.
- Comparison of patient outcomes with typical bipolar disorder treatment responses.
Main Results:
- Three elderly patients showed protracted, unsatisfactory ECT courses with frequent relapses.
- Discontinuation of maintenance ECT and initiation of pharmacotherapy (lithium, carbamazepine, or valproic acid) led to sustained improvement.
- These cases contrast with typical bipolar disorder patients who respond well to maintenance ECT.
Conclusions:
- Maintenance ECT may be unsuitable for certain elderly patients with atypical bipolar disorder.
- Combination pharmacotherapy with lithium and anticonvulsants can be effective for treatment-resistant atypical bipolar disorder.
- Identifying and managing atypical bipolar disorder requires careful consideration of patient-specific factors and treatment responses.